⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL622255 | 0.62 | — | — | |
| SCHEMBL9935782 | 0.62 | — | — | |
| SCHEMBL27472571 | 0.62 | INMT (0.39) | — | |
| SCHEMBL761333 | 0.62 | — | — | |
| SCHEMBL8975369 | 0.62 | — | — | |
| SCHEMBL1628000 | 0.62 | — | — | |
| SCHEMBL34680 | 0.62 | — | — | |
| SCHEMBL17102937 | 0.62 | — | — | |
| Hydrochloric Acid SCHEMBL10764569 | 0.61 | — | — | |
| Water SCHEMBL5807420 | 0.61 | INMT (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0837052-B1 | BICYCLIC AMINO DERIVATIVES AND PGD 2 ANTAGONIST CONTAINING THE SAME | SHIONOGI & CO (JP) | 2006-08-23 | — | — | EP | claimed |
| US-6498190-B1 | TREATMENT OF NASAL OCCLUSION AND MAST CELL DYSFUNCTION DISEASES; ANTIINFLAMMATORY AGENTS | SHIONOGI & CO., LTD. (JP) | 2002-12-24 | — | — | US | claimed |
| US-6384075-B1 | TREATING DISEASES IN WHICH MAST CELL DYSFUNCTION IS INVOLVED | SHIONOGI & CO., LTD. (JP) | 2002-05-07 | — | — | US | claimed |
| US-6172113-B1 | Bicyclic amino derivatives and PGD2 antagonist containing the same | SHIONOGI & CO., LTD. (JP) | 2001-01-09 | — | — | US | claimed |
| CN-1193315-A | Bicyclic amino derivatives and PGDZ antagonist containing same | SHIONOGI PHARMACEUTIC K K (JP) | 1998-09-16 | — | — | CN | claimed |
| EP-0837052-A1 | BICYCLIC AMINO DERIVATIVES AND PGD 2 ANTAGONIST CONTAINING THE SAME | SHIONOGI & CO., LTD. (JP) | 1998-04-22 | — | — | EP | claimed |
| EP-2089373-A1 | STAT3/5 ACTIVATION INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2009-08-19 | — | — | EP | disclosed |
| EP-1957073-A2 | MEDICINAL DRUG | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2008-08-20 | — | — | EP | disclosed |
| WO-2008044667-A1 | STAT3/5 ACTIVATION INHIBITOR | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2008-04-17 | — | — | WO | disclosed |
| WO-2007066784-A2 | DIARYLETHER DERIVATIVES AS ANTITUMOR AGENTS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-06-14 | — | — | WO | disclosed |
| EP-1773797-A2 | AROMATIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-04-18 | — | — | EP | disclosed |
| EP-0837052-B1 | BICYCLIC AMINO DERIVATIVES AND PGD 2 ANTAGONIST CONTAINING THE SAME | SHIONOGI & CO (JP) | 2006-08-23 | — | — | EP | disclosed |
| WO-2006014012-A2 | AROMATIC COMPOUNDS | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-02-09 | — | — | WO | disclosed |
| CN-1134411-C | Bicyclic amino derivatives and PGDZ antagonist containing same | C&C��ҩ�о��� | 2004-01-14 | — | — | CN | disclosed |
| US-6498190-B1 | TREATMENT OF NASAL OCCLUSION AND MAST CELL DYSFUNCTION DISEASES; ANTIINFLAMMATORY AGENTS | SHIONOGI & CO., LTD. (JP) | 2002-12-24 | — | — | US | disclosed |
| US-6384075-B1 | TREATING DISEASES IN WHICH MAST CELL DYSFUNCTION IS INVOLVED | SHIONOGI & CO., LTD. (JP) | 2002-05-07 | — | — | US | disclosed |
| US-6172113-B1 | Bicyclic amino derivatives and PGD2 antagonist containing the same | SHIONOGI & CO., LTD. (JP) | 2001-01-09 | — | — | US | disclosed |
| CN-1193315-A | Bicyclic amino derivatives and PGDZ antagonist containing same | SHIONOGI PHARMACEUTIC K K (JP) | 1998-09-16 | — | — | CN | disclosed |
| EP-0837052-A1 | BICYCLIC AMINO DERIVATIVES AND PGD 2 ANTAGONIST CONTAINING THE SAME | SHIONOGI & CO., LTD. (JP) | 1998-04-22 | — | — | EP | disclosed |